The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting

References

• De Ioris MA, Crocoli A, Contoli B, et al. Local control in metastatic neuroblastoma in children over 1 year of age. BMC Cancer. 2015;15:79. doi:10.1186/s12885-015-1082-7.
   PubMed Web of Science ®Google Scholar
• Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Neuroblastoma. Jpn J Clin Oncol. 2018;48(3):214–241. doi:10.1093/jjco/hyx176.
   PubMed Web of Science ®Google Scholar
• van Heerden J, Kruger M. Management of neuroblastoma in limited-resource settings. World J Clin Oncol. 2020;11(8):629–643. doi:10.5306/wjco.v11.i8.629.
   PubMed Web of Science ®Google Scholar
• Nuchtern JG, London WB, Barnewolt CE, et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children’s Oncology Group study. Ann Surg. 2012;256(4):573–580. doi:10.1097/SLA.0b013e31826cbbbd.
   PubMed Web of Science ®Google Scholar
• Hero B, Simon T, Spitz R, et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008;26(9):1504–1510. doi:10.1200/JCO.2007.12.3349.
   PubMed Web of Science ®Google Scholar
• Parikh N, Howard S, Chantada G, Israels T, International Society of Pediatric Oncology, et al. SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62(8):1305–1316. doi:10.1002/pbc.25501.
   PubMed Web of Science ®Google Scholar
• Du L, Liu L, Zhang C, et al. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. J Pediatr Surg. 2014;49(4):528–533. doi:10.1016/j.jpedsurg.2013.11.061.
   PubMed Web of Science ®Google Scholar
• Rojas Y, Jaramillo S, Lyons K, et al. The optimal timing of surgical resection in high-risk neuroblastoma. J Pediatr Surg. 2016;51(10):1665–1669. doi:10.1016/j.jpedsurg.2016.05.021.
   PubMed Web of Science ®Google Scholar
• Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31(6):752–758. doi:10.1200/JCO.2012.45.9339.
   PubMed Web of Science ®Google Scholar
• Zwaveling S, Tytgat GA, van der Zee DC, Wijnen MH, Heij HA. Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95% tumour resection suffice? Pediatr Surg Int. 2012;28(10):953–959. doi:10.1007/s00383-012-3109-3.
   PubMed Web of Science ®Google Scholar
• Brisse HJ, McCarville MB, Granata C, International Neuroblastoma Risk Group Project, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261(1):243–257. doi:10.1148/radiol.11101352.
   PubMed Web of Science ®Google Scholar
• Cotterill S, Pearson A, Pritchard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992. Eur J Cancer. 2000;36(7):901–908. doi:10.1016/S0959-8049(00)00058-7.
   PubMed Web of Science ®Google Scholar
• Kiely E. A technique for excision of abdominal and pelvic neuroblastomas. Ann R Coll Surg Engl. 2007;89(4):342–348. doi:10.1308/003588407X179071.
   PubMed Web of Science ®Google Scholar
• Murphy JM, La Quaglia MP. Advances in the surgical treatment of neuroblastoma: a review. Eur J Pediatr Surg. 2014;24(6):450–456. doi:10.1055/s-0034-1396421.
   PubMed Web of Science ®Google Scholar
• Avanzini S, Pio L, Erminio G, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer. 2017;64(11):e26605. doi:10.1002/pbc.26605.
   Web of Science ®Google Scholar
• van Heerden J, Kruger M, Esterhuizen T, South African Children’s Cancer Study Group, et al. The importance of local control management in high-risk neuroblastoma in South Africa. Pediatr Surg Int. 2020;36(4):457–469. doi:10.1007/s00383-020-04627-x.
   PubMed Web of Science ®Google Scholar
• Hadley G, van Heerden J. High-risk neuroblastoma in a sub-Saharan African country: telling it like it is. Trop Doct. 2017;47(4):370–374. doi:10.1177/0049475517704363.
   PubMed Web of Science ®Google Scholar
• Van Heerden J, Hendricks M, Geel J, et al. Overall survival for neuroblastoma in South Africa between 2000 and 2014. Pediatr Blood Cancer. 2019;66(11):e27944. doi:10.1002/pbc.27944. Epub 2019 Jul 31.
   PubMed Web of Science ®Google Scholar
• van Heerden J, Esterhuizen T, Kruger M. Inequity in paediatric oncology in South Africa – the neuroblastoma case study. SA Journal of Oncology. 2021;5:12. doi:10.4102/sajo.v5i0.163.
   Google Scholar
• Temple WC, Vo KT, Matthay KK, Balliu B, et al. Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma. Cancer Med. 2021;10(7):2232–2241. doi:10.1002/cam4.3663.
   PubMed Web of Science ®Google Scholar
• Park JR, Bagatell R, Cohn SL, et al. Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute Clinical Trials planning meeting. J Clin Oncol. 2017;35(22):2580–2587. doi:10.1200/JCO.2016.72.0177.
   PubMed Web of Science ®Google Scholar
• Li K, Dong K, Gao J, Yao W, Xiao X, Zheng S. Neuroblastoma management in Chinese children. J Invest Surg. 2012;25(2):86–92. doi:10.3109/08941939.2011.605203.
   PubMed Web of Science ®Google Scholar
• Berthold F, Spix C, Kaatsch P, Lampert F. Incidence, survival, and treatment of localized and metastatic neuroblastoma in germany 1979–2015. Paediatr Drugs. 2017;19(6):577–593. doi:10.1007/s40272-017-0251-3.
   PubMed Web of Science ®Google Scholar
• Aksoylar S, Varan A, Vergin C, et al. Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group. J Cancer Res Ther. 2017;13(2):284–290. doi:10.4103/0973-1482.183205.
   PubMed Web of Science ®Google Scholar
• Ryan AL, Akinkuotu A, Pierro A, Morgenstern DA, Irwin MS. The role of surgery in high-risk neuroblastoma. J Pediatr Hematol Oncol. 2020;42(1):1–7. doi:10.1097/MPH.0000000000001607.
   PubMed Web of Science ®Google Scholar
• Holmes K, Pötschger U, Pearson ADJ, International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN), et al. Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: a report from the HR-NBL1/SIOPEN study. J Clin Oncol. 2020;38(25):2902–2915. doi:10.1200/JCO.19.03117.
   PubMed Web of Science ®Google Scholar
• Loh AHP, Angelina C, Wong MK, et al. Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse. Front Oncol. 2022;12(9):939460. doi:10.3389/fonc.2022.939460.
   PubMedGoogle Scholar